MedTrace Logo

A One-Week Crossover Dispensing Evaluation of New Daily Wear Soft Contact Lenses

NCT03306641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2020-09-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period 1 week compared to nelfilcon A (control).

Conditions

  • Myopia

Interventions

DEVICE

Test Contact Lens

Daily disposable contact lens

DEVICE

Nelfilcon A

Focus Dailies All Day Comfort contact lens (nelfilcon A)

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-28
Primary Completion
2017-08-31
Completion
2017-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306641 on ClinicalTrials.gov